Trials / Completed
CompletedNCT02176421
A Prospective, Open Label Study Evaluating JUVÉDERM® VOLBELLA With Lidocaine Treatment for the Correction of Skin Depressions in the Infra-orbital Area
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, open label, study evaluating JUVÉDERM® VOLBELLA with lidocaine treatment for the correction of skin depressions in the infra-orbital area (under the eyes)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | VOLBELLA® with lidocaine | VOLBELLA® with lidocaine administered to correct skin depression during initial treatment and optional top-up treatment 14 days later. |
Timeline
- Start date
- 2014-05-15
- Primary completion
- 2014-08-18
- Completion
- 2015-07-03
- First posted
- 2014-06-27
- Last updated
- 2019-04-16
- Results posted
- 2015-07-16
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02176421. Inclusion in this directory is not an endorsement.